| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Dizepam | Diazepam EP Impurity A | VL3230001 | View CAS 1088-11-5 |
| Diazepam | Diazepam EP Impurity B | VL3230002 | View CAS 6021-21-2 |
| Diazepam | Diazepam EP Impurity C | VL3230003 | View CAS 5220-02-0 |
| Diazepam | Diazepam EP Impurity D | VL3230004 | View CAS 1022-13-5 |
| Diazepam | Diazepam EP Impurity E | VL3230005 | View CAS 20927-53-1 |
[rfq_list]
| Catalogue No. | VL3230004 |
| CAS No. | 1022-13-5 |
| Molecular Formula | C14H12ClNO |
| Molecular Weight | 245.7 |
| Parent drug | Diazepam |
| IUPAC Name | 5-chloro-2-(methylamino)phenyl]phenylmethanone |
| Synonyms | 2-(Methylamino)-5-chlorobenzophenone; Ro 5-4365; [5-Chloro-2-(methylamino)phenyl]phenylmethanone; USP Temazepam Impurity A; |
| References | Zhang, Xin, et al. “Determination of Emerging Chlorinated Byproducts of Diazepam in Drinking Water.” Chemosphere, vol. 218, Mar. 2019, pp. 223–31, https://doi.org/10.1016/j.chemosphere.2018.11.076.?Crestani, Florence, et al. “Molecular Targets for the Myorelaxant Action of Diazepam.” Molecular Pharmacology, vol. 59, no. 3, Mar. 2001, pp. 442–45, https://doi.org/10.1124/mol.59.3.442.? |
| Status | Not Available |
| ListName | Diazepam EP Impurity D |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
